An ALS Patient and Researcher Makes the Case for Wider Use of Polygenic Analysis
mcmurryjulie / Pixabay

An ALS Patient and Researcher Makes the Case for Wider Use of Polygenic Analysis

​According to a story from forum.facmedicine.com, Dr. Rahul Desikan has been dedicated to the study and research of neurological disease such as amyotrophic lateral sclerosis (ALS). Then, in a cruel…

Continue Reading An ALS Patient and Researcher Makes the Case for Wider Use of Polygenic Analysis
Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It
Source: Pixabay.com

Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

Cedric Rutland, a pulmonologist at Pacific Pulmonary Medical Group has shared his experience, research, and thoughts on cognitive bias in an effort to spread awareness for the issue, and hopefully,…

Continue Reading Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

A Gene Therapy for X-Linked Myotubular Myopathy is Making a Difference

According to a story from sciencemag.org, an experimental gene therapy for the rare genetic disorder X-linked myotubular myopathy is starting to produce significant improvements for patients. A devastating disease that…

Continue Reading A Gene Therapy for X-Linked Myotubular Myopathy is Making a Difference

MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria

An article in Globe Newswire quotes National Institute of Health statistics for malaria as being between 300 to 500 million cases worldwide resulting in 1.5 to 2.7 million deaths annually. People living…

Continue Reading MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria

First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA

Transthyretin-Mediated Amyloidosis Cardiomyopathy The FDA has just approved the very first treatment for hereditary or wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM).  ATTR-CM is a rare disease that occurs when amyloids, an…

Continue Reading First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA
After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
Free-Photos / Pixabay

After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate

According to a story from KTVZ, Jill Noe and Whitney Bliesner have always shared a special bond. They are twins, now 34 years old. Despite their closeness, they do share…

Continue Reading After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
Love for his Family Convinced This Multiple Sclerosis Patient to try Experimental Drug
stevepb / Pixabay

Love for his Family Convinced This Multiple Sclerosis Patient to try Experimental Drug

According to a story from cbc.ca, Lyle Daniels became one of the first patients to try an experimental treatment called Ocrevus for his progressive multiple sclerosis. Just recently, the province…

Continue Reading Love for his Family Convinced This Multiple Sclerosis Patient to try Experimental Drug

This New Method of Screening Could Diagnose and Treat Rare Diseases More Quickly

According to a story from Science Daily, a team of scientists affiliated with UT Southwestern's Children's Medical Center Research Institute are hard at work pioneering an innovative new approach that…

Continue Reading This New Method of Screening Could Diagnose and Treat Rare Diseases More Quickly
Close Menu